CRS: JHU
Position: CTU Leader for HPTN Studies
CRS: BJMC
Position: Lab Manager
Position: Research Clinician
Position: Study Coordinator
Position: Clinical Coordinator
Position: CRS Coordinator
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
